These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 24492724

  • 1. Berberine inhibits fluphenazine-induced up-regulation of CDR1 in Candida albicans.
    Zhu SL, Yan L, Zhang YX, Jiang ZH, Gao PH, Qiu Y, Wang L, Zhao MZ, Ni TJ, Cai Z, Tian SJ, Zang CX, Zhang DZ, Jiang YY.
    Biol Pharm Bull; 2014; 37(2):268-73. PubMed ID: 24492724
    [Abstract] [Full Text] [Related]

  • 2. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans Isolates.
    Xu Y, Quan H, Wang Y, Zhong H, Sun J, Xu J, Jia N, Jiang Y.
    Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
    [Abstract] [Full Text] [Related]

  • 3. Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.
    Li DD, Xu Y, Zhang DZ, Quan H, Mylonakis E, Hu DD, Li MB, Zhao LX, Zhu LH, Wang Y, Jiang YY.
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6016-27. PubMed ID: 24060867
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.
    Shi G, Shao J, Wang T, Wu D, Wang C.
    Biomed Pharmacother; 2017 Sep; 93():709-712. PubMed ID: 28700974
    [Abstract] [Full Text] [Related]

  • 5. Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans.
    Wu S, Jia W, Lu Y, Jiang H, Huang C, Tang S, Du L.
    BMC Microbiol; 2024 Jun 07; 24(1):196. PubMed ID: 38849761
    [Abstract] [Full Text] [Related]

  • 6. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
    Khajeh E, Hosseini Shokouh SJ, Rajabibazl M, Roudbary M, Rafiei S, Aslani P, Farahnejad Z.
    Br J Biomed Sci; 2016 Jun 07; 73(1):44-8. PubMed ID: 27182677
    [Abstract] [Full Text] [Related]

  • 7. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M, Niimi K, Takano Y, Holmes AR, Fischer FJ, Uehara Y, Cannon RD.
    J Antimicrob Chemother; 2004 Dec 07; 54(6):999-1006. PubMed ID: 15486081
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans.
    Manoharlal R, Gaur NA, Panwar SL, Morschhäuser J, Prasad R.
    Antimicrob Agents Chemother; 2008 Apr 07; 52(4):1481-92. PubMed ID: 18268086
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Shukla S, Yadav V, Mukhopadhyay G, Prasad R.
    Eukaryot Cell; 2011 Oct 07; 10(10):1357-66. PubMed ID: 21856931
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills Candida albicans.
    Suchodolski J, Muraszko J, Bernat P, Krasowska A.
    Int J Mol Sci; 2021 May 14; 22(10):. PubMed ID: 34069257
    [Abstract] [Full Text] [Related]

  • 15. Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans.
    Liu Z, Myers LC.
    Antimicrob Agents Chemother; 2017 Nov 14; 61(11):. PubMed ID: 28807920
    [Abstract] [Full Text] [Related]

  • 16. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA, Manoharlal R, Saini P, Prasad T, Mukhopadhyay G, Hoefer M, Morschhäuser J, Prasad R.
    Biochem Biophys Res Commun; 2005 Jun 24; 332(1):206-14. PubMed ID: 15896319
    [Abstract] [Full Text] [Related]

  • 17. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance.
    de Micheli M, Bille J, Schueller C, Sanglard D.
    Mol Microbiol; 2002 Mar 24; 43(5):1197-214. PubMed ID: 11918807
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK, Thota CK, Verma SD, Sharma J, Rawal MK, Ravikumar B, Sen S, Chauhan N, Lynn AM, Chauhan VS, Prasad R.
    J Biol Chem; 2013 Jun 07; 288(23):16775-16787. PubMed ID: 23592791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.